Picture of Chemring logo

CHG Chemring News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsBalancedMid CapHigh Flyer

REG - Chemring Group PLC - Director Declaration

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241114:nRSN2425Ma&default-theme=true

RNS Number : 2425M  Chemring Group PLC  14 November 2024

FOR IMMEDIATE
RELEASE
                              14 NOVEMBER 2024

 

 

CHEMRING GROUP PLC

 

Director Declaration

 

 

In accordance with Listing Rule 9.6.14, Chemring Group PLC (the "Company")
announces that Carl-Peter Forster, a director of the Company, will take up an
appointment as a non-executive director and Chair-designate of Keller Group
plc on 16 December 2024 and will be appointed as Chair of Keller Group plc on
5 March 2025. As previously announced, Mr Forster will step down as a director
and Chairman of the Board of the Company on 30 November 2024.

 

 

-ENDS-

 

 

 

For further information:

 

Sarah Ellard                Group Legal Director, Chemring Group
PLC              07710 553757

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNGPGRGGUPCUMC

Recent news on Chemring

See all news